Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

J Aparicio-Blanco, L Sanz-Arriazu, R Lorenzoni… - International Journal of …, 2020 - Elsevier
Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …
被引用次数：38 相关文章

Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.

J Aparicio-Blanco, L Sanz-Arriazu… - International Journal …, 2020 - europepmc.org
Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

J Aparicio-Blanco, L Sanz-Arriazu… - International …, 2020 - pubmed.ncbi.nlm.nih.gov
Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

J Aparicio Blanco, L Sanz-Arriazu, R Lorenzoni… - 2020 - docta.ucm.es
Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …

[引用][C] Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

J Aparicio-Blanco, L Sanz-Arriazu… - International Journal of …, 2020 - cir.nii.ac.jp
Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials:
Nanomedicine approaches to improve their efficacy | CiNii Research CiNii 国立情報学研究所 …
[PDF] ucm.es

[PDF][PDF] Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy

J Aparicio-Blanco, L Sanz-Arriazu… - International Journal of …, 2020 - docta.ucm.es
Even though substantial advances in understanding glioma pathogenesis have prompted a
more rational design of potential therapeutic strategies, glioblastoma multiforme remains an …